NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹433 Cr | ₹356 Cr | ₹287 Cr | ₹277 Cr | ₹207 Cr |
What is the latest Total Liabilities ratio of NGL FINECHEM ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹433 Cr |
| Mar2024 | ₹356 Cr |
| Mar2023 | ₹287 Cr |
| Mar2022 | ₹277 Cr |
| Mar2021 | ₹207 Cr |
How is Total Liabilities of NGL FINECHEM Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹433 Cr | 21.90 | |
| Mar2024 | ₹356 Cr | 23.85 | |
| Mar2023 | ₹287 Cr | 3.67 | |
| Mar2022 | ₹277 Cr | 33.53 | |
| Mar2021 | ₹207 Cr | - | |
Compare Total Liabilities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹800.7 Cr | 1% | -2.8% | -34.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 1% |
-2.8% |
-34.6% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses